15.21
price down icon8.65%   -1.44
after-market 시간 외 거래: 15.19 -0.02 -0.13%
loading
전일 마감가:
$16.65
열려 있는:
$16.22
하루 거래량:
279.21K
Relative Volume:
0.98
시가총액:
$452.32M
수익:
-
순이익/손실:
$11.77M
주가수익비율:
26.29
EPS:
0.5785
순현금흐름:
$-19.23M
1주 성능:
-13.63%
1개월 성능:
+16.20%
6개월 성능:
-40.84%
1년 성능:
-33.58%
1일 변동 폭
Value
$14.87
$16.22
1주일 범위
Value
$14.87
$17.80
52주 변동 폭
Value
$11.87
$29.79

Tourmaline Bio Inc Stock (TRML) Company Profile

Name
명칭
Tourmaline Bio Inc
Name
전화
646-481-9832
Name
주소
27 WEST 24TH STREET, NEW YORK
Name
직원
0
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
TRML's Discussions on Twitter

TRML을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TRML
Tourmaline Bio Inc
15.21 452.32M 0 11.77M -19.23M 0.5785
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-06 개시 Wedbush Outperform
2024-12-06 개시 BMO Capital Markets Outperform
2024-11-11 재확인 H.C. Wainwright Buy
2023-12-15 개시 Jefferies Buy
2023-12-04 재개 H.C. Wainwright Buy
2023-11-17 개시 Truist Buy
2023-10-31 개시 Guggenheim Buy
2023-10-25 개시 Piper Sandler Overweight
2022-10-20 개시 H.C. Wainwright Buy
2022-07-05 다운그레이드 Morgan Stanley Overweight → Equal-Weight
모두보기

Tourmaline Bio Inc 주식(TRML)의 최신 뉴스

pulisher
03:29 AM

Swiss National Bank Takes Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

03:29 AM
pulisher
Mar 25, 2025

Leading Factor Driving the Thyroid Eye Disease (TED) Market in 2025: Thyroid Disorders And Their Influence ... - WhaTech

Mar 25, 2025
pulisher
Mar 20, 2025

ProfittoPath - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Sold by AlphaQuest LLC - Defense World

Mar 20, 2025
pulisher
Mar 17, 2025

Tourmaline Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 17, 2025
pulisher
Mar 16, 2025

Alumis Inc. (NASDAQ:ALMS) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Mar 16, 2025
pulisher
Mar 16, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Mar 16, 2025
pulisher
Mar 16, 2025

Tourmaline Bio (NASDAQ:TRML) Stock Price Expected to Rise, Wedbush Analyst Says - Defense World

Mar 16, 2025
pulisher
Mar 16, 2025

HC Wainwright Raises Tourmaline Bio (NASDAQ:TRML) Price Target to $50.00 - Defense World

Mar 16, 2025
pulisher
Mar 14, 2025

H.C. Wainwright raises Tourmaline Bio stock target to $50 By Investing.com - Investing.com Canada

Mar 14, 2025
pulisher
Mar 14, 2025

Tourmaline Bio price target raised to $43 from $42 at Wedbush - TipRanks

Mar 14, 2025
pulisher
Mar 14, 2025

H.C. Wainwright raises Tourmaline Bio stock target to $50 - Investing.com India

Mar 14, 2025
pulisher
Mar 14, 2025

Wedbush Lifts Price Target on Tourmaline Bio to $43 From $42, Keeps Outperform Rating - Marketscreener.com

Mar 14, 2025
pulisher
Mar 14, 2025

Novo Nordisk (0QIU) Gets a Buy from UBS - The Globe and Mail

Mar 14, 2025
pulisher
Mar 14, 2025

Tourmaline Bio’s 2024 Financial Results and Strategic Advances - TipRanks

Mar 14, 2025
pulisher
Mar 13, 2025

Tourmaline Bio shares fall as Q4 loss widens - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Tourmaline Bio shares fall as Q4 loss widens By Investing.com - Investing.com UK

Mar 13, 2025
pulisher
Mar 13, 2025

TOURMALINE BIO Earnings Results: $TRML Reports Quarterly Earnings - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Tourmaline Bio, Inc. SEC 10-K Report - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

Tourmaline Bio's cash position to provide cash runway into second half of 2027 -March 13, 2025 at 07:39 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

Tourmaline Bio, Inc. Announces Over-Enrolled Phase 2 TRANQUILITY Trial and Strengthens Cardiovascular Scientific Advisory Board Amid Positive Financial Outlook - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business - Bluefield Daily Telegraph

Mar 13, 2025
pulisher
Mar 13, 2025

Tourmaline Bio Secures 2.5-Year Cash Runway with $294M, Accelerates Key Clinical Trials - StockTitan

Mar 13, 2025
pulisher
Mar 11, 2025

Tourmaline Bio (TRML) Projected to Post Earnings on Tuesday - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Wedbush Forecasts Tourmaline Bio FY2024 Earnings - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Tourmaline Bio (NASDAQ:TRML) Research Coverage Started at Wedbush - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Rhumbline Advisers Has $722,000 Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

Tourmaline Bio rises as Wedbush initiates with Outperform - MSN

Mar 06, 2025
pulisher
Mar 06, 2025

This Tourmaline Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - NewsBreak

Mar 06, 2025
pulisher
Mar 06, 2025

Wedbush bullish on Tourmaline Bio, initiates with an Outperform - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Wedbush Initiates Coverage on Tourmaline Bio With Outperform Rating, $42 Price Target - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

Wedbush Initiates Tourmaline Bio at Outperform With $42 Price Target -March 06, 2025 at 07:22 am EST - Marketscreener.com

Mar 06, 2025
pulisher
Mar 05, 2025

We Tested Over 25 Curling Irons. These 13 Are the Best - MarieClaire.com

Mar 05, 2025
pulisher
Mar 03, 2025

Tourmaline Bio to Present at the Leerink Partners Global Healthcare Conference 2025 - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

Volatus Aerospace and Draganfly Expand Collaboration to Service High-Value Geospatial Power Utility Customers - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

3 Reasons to Buy American Express Stock Like There's No Tomorrow - The Globe and Mail

Mar 03, 2025
pulisher
Mar 03, 2025

When and Where to Catch Tourmaline Bio's Next Investor Presentation - StockTitan

Mar 03, 2025
pulisher
Feb 28, 2025

Brokers Set Expectations for Tourmaline Bio FY2024 Earnings - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Truist maintains $74 target on Tourmaline Bio stock, reiterates buy By Investing.com - Investing.com UK

Feb 27, 2025
pulisher
Feb 27, 2025

Lifesci Capital Predicts Tourmaline Bio FY2024 Earnings - Defense World

Feb 27, 2025
pulisher
Feb 27, 2025

Financial Survey: X4 Pharmaceuticals (NASDAQ:XFOR) & Tourmaline Bio (NASDAQ:TRML) - Defense World

Feb 27, 2025
pulisher
Feb 26, 2025

Lifesci Capital Initiates Coverage on Tourmaline Bio (NASDAQ:TRML) - Armenian Reporter

Feb 26, 2025
pulisher
Feb 25, 2025

Tourmaline Bio (NASDAQ:TRML) Coverage Initiated by Analysts at Lifesci Capital - Defense World

Feb 25, 2025
pulisher
Feb 24, 2025

LifeSci Capital Initiates Coverage of Tourmaline Bio (TRML) with Outperform Recommendation - MSN

Feb 24, 2025
pulisher
Feb 24, 2025

Talaris Therapeutics stock hits 52-week low at $12.06 By Investing.com - Investing.com Australia

Feb 24, 2025
pulisher
Feb 24, 2025

Talaris Therapeutics stock hits 52-week low at $12.06 - Investing.com

Feb 24, 2025
pulisher
Feb 24, 2025

This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Feb 24, 2025
pulisher
Feb 21, 2025

Vaxcyte (NASDAQ:PCVX) & Tourmaline Bio (NASDAQ:TRML) Financial Review - Defense World

Feb 21, 2025
pulisher
Feb 19, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $54.00 Average PT from Brokerages - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Feb 19, 2025

Tourmaline Bio Inc (TRML) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
자본화:     |  볼륨(24시간):